Good quality Vitamin Ad3e Injection - Tylosin Tartrate Injection – Jizhong
Good quality Vitamin Ad3e Injection - Tylosin Tartrate Injection – Jizhong Detail:
Tylosin Tartrate Injection
Specification:
5%,10%,20%
Description:
Tylosin, a macrolide antibiotic, is active against particularly gram-positive bacteria, some
Spirochetes (including leptospira); actinomyces, mycoplasmas (pplo), haemophilus
Pertussis, moraxella bovis and some gram-negative cocci. after parenteral administration,
Therapeutically active blood-concentrations of tylosin are reached within 2 hours.
Indications:
Infections caused by micro-organisms susceptible to tylosin, like e.g. respiratory tract
Infections in cattle, sheep and pigs, dysentery doyle in pigs, dysentery and arthritis caused
by mycoplasmas, mastitis and endometritis.
Dosage And Administration:
For intramuscular administration.
General: 2mg-5mg tylosin, per 10 kg bodyweight daily, during 3-5 days.
Contraindications:
Hypersensitivity to tylosin.
Concurrent administration with penicillins, cephalosporines, quinolones and cycloserine.
Withdrawal Times:
Meat:8 days
Milk:4 days
Warning:
Keep out of the touch of children
Storage:
Store in a dry, dark place between 8°c and 15°c.
Product detail pictures:
Related Product Guide:
Dedicated to strict high-quality management and considerate purchaser support, our experienced employees members are usually available to discuss your specifications and be certain full shopper satisfaction for Good quality Vitamin Ad3e Injection - Tylosin Tartrate Injection – Jizhong , The product will supply to all over the world, such as: Uruguay, Thailand, Adelaide, The credibility is the priority, and the service is the vitality. We promise we have now the ability to offer excellent quality and reasonable price items for customers. With us, your safety is guaranteed.
By Mignon from Atlanta - 2018.06.18 19:26
Perfect services, quality products and competitive prices, we have work many times, every time is delighted, wish continue to maintain!
By Elma from Boston - 2018.12.14 15:26